BioXcel Therapeutics
BTAI
#9513
Rank
NZ$44.8 M
Marketcap
$1.10
Share price
2.37%
Change (1 day)
-86.23%
Change (1 year)

P/S ratio for BioXcel Therapeutics (BTAI)

P/S ratio as of November 2024 (TTM): 10.9

According to BioXcel Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.3536. At the end of 2024 the company had a P/S ratio of 20.0.

P/S ratio history for BioXcel Therapeutics from 2018 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202420.0-68.05%
202362.6-96.1%
2022> 1000
2021N/A
2020N/A
2019N/A
2018N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA